Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antiganglioside antibody frequency in routine clinical care settings.
Giesche N, Böhm-Gonzalez ST, Kleiser B, Kowarik MC, Dubois E, Stransky E, Armbruster M, Grimm A, Marquetand J. Giesche N, et al. Among authors: kowarik mc. Eur J Neurol. 2024 Jul;31(7):e16290. doi: 10.1111/ene.16290. Epub 2024 Mar 31. Eur J Neurol. 2024. PMID: 38556758 Free PMC article.
Anti-sulfatide antibodies in neurological disorders: should we test?
Kleiser B, Giesche N, Kowarik MC, Dubois E, Armbruster M, Grimm A, Marquetand J. Kleiser B, et al. Among authors: kowarik mc. J Neurol. 2024 Dec;271(12):7613-7618. doi: 10.1007/s00415-024-12668-8. Epub 2024 Sep 3. J Neurol. 2024. PMID: 39225745 Free PMC article.
In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis.
Vasilenko N, Tieck MP, Michel T, Schembecker S, Schwarz P, Guenther A, Ruschil C, Poli S, Ziemann U, Giede-Jeppe A, Gabernet G, Dulovic A, Kowarik MC. Vasilenko N, et al. Among authors: kowarik mc. Front Immunol. 2024 Dec 17;15:1487523. doi: 10.3389/fimmu.2024.1487523. eCollection 2024. Front Immunol. 2024. PMID: 39742283 Free PMC article.
Real-world therapy management of patients with multiple sclerosis receiving cladribine tablets beyond year 4 - Results from a German cladribine cohort.
Kowarik MC, Ernst M, Woitschach L, Cepek L, Rau D, Kühnler B, Schlemilch-Paschen S, Grothe C, Schwab M, Jöstingmeyer P, Kleinschnitz C, Pul R. Kowarik MC, et al. Mult Scler Relat Disord. 2024 Aug;88:105704. doi: 10.1016/j.msard.2024.105704. Epub 2024 Jun 7. Mult Scler Relat Disord. 2024. PMID: 38878625 Free article.
48 results